CLF065
/ Scripps Research Institute, AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 11, 2025
OPUS: CLF065 for Chronic Pouchitis
(clinicaltrials.gov)
- P2 | N=20 | Not yet recruiting | Sponsor: Calibr, a division of Scripps Research
New P2 trial • Gastrointestinal Disorder • Inflammation
1 to 1
Of
1
Go to page
1